<?xml version="1.0" encoding="UTF-8"?>
<p>β-Eudesmol, a bicyclic sesquiterpenoid alkene alcohol, is a major component in atractylis (
 <italic>Atractylodes lancea</italic> (Thunb.) DC) (26.0%) [
 <xref rid="B22-ijms-22-02380" ref-type="bibr">22</xref>], araucaria (
 <italic>Neocallitropsis pancheri</italic> (Carrière) de Laub.) (25.9%) [
 <xref rid="B26-ijms-22-02380" ref-type="bibr">26</xref>], blue cypress (
 <italic>Callitris intratropica</italic> R.T. Baker and H.B. Sm.) (14.4%) [
 <xref rid="B28-ijms-22-02380" ref-type="bibr">28</xref>], European valerian (
 <italic>Valeriana officinalis</italic> L.) (0–8.3%), amyris (
 <italic>Amyris balsamifera</italic> L.) (3.2–7.9%), blue tansy (
 <italic>Tanacetum annuum</italic> L.) (3.5–6.7%) [
 <xref rid="B117-ijms-22-02380" ref-type="bibr">117</xref>], hinoki leaf (
 <italic>Chamaecyparis obtusa</italic> (Siebold and Zucc.) Endl.) (6.5%), 
 <italic>Eucalyptus smithii</italic> (6.3%), emerald cypress (
 <italic>Callitris columellaris</italic> F.Muell.) (5.7%), and vetiver (
 <italic>Vetiveria zizanioides</italic> (L.) Nash) (0–5.2%) [
 <xref rid="B22-ijms-22-02380" ref-type="bibr">22</xref>]. β-Eudesmol is a known anti-angiogenic agent both in vitro and in vivo via blocking of the extracellular signal-regulated kinase (ERK) signaling pathway [
 <xref rid="B201-ijms-22-02380" ref-type="bibr">201</xref>]. β-Eudesmol showed significant in vitro antiplatelet aggregation activity and best be avoided in childbirth [
 <xref rid="B22-ijms-22-02380" ref-type="bibr">22</xref>]. Based on their β-eudesmol content, atractylis, araucaria, and blue cypress oils may be fetotoxic and may inhibit blood clotting; they should be avoided during pregnancy and lactation.
</p>
